Arranta Bio announces the acquisition of Captozyme™, creating a Center of Excellence for microbiome development and clinical supply

Corporate Breaking News

Home : Arranta Bio announces the acquisition of Captozyme™, creating a Center of Excellence for microbiome development and clinical supply

Nov 13 2019	Arranta Bio announces the acquisition of Captozyme™, creating a Center of Excellence for microbiome development and clinical supply
WATERTOWN, Mass., Nov. 13, 2019 /PRNewswire/ -- Arranta Bio ("Arranta") announced today the acquisition of Captozyme™, and with it the establishment of Arranta's Center of Excellence for process and analytical development and early clinical supply for microbiome clients with the transfer...


Source:https://www.prnewswire.com:443/news-releases/arranta-bio-announces-the-acquisition-of-captozyme-creating-a-center-of-excellence-for-microbiome-development-and-clinical-supply-300956937.html

Related News
» HiSea Project to Launch the First Prototype of a High-Resolution System Providing Data on Sea Water Quality » Supreme Court grapples with Trump cancellation of DACA, impact on immigrant families